A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma

Published:2020-09-11 Issue:9 Volume:43 Page:273-282
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Faiena Izak,Comin-Anduix Begoña,Berent-Maoz Beata,Bot Adrian,Zomorodian Nazy,Sachdeva Ankush,Said Jonathan,Cheung-Lau Gardenia,Pang Jia,Macabali Mignonette,Chodon Thinle,Wang Xiaoyan,Cabrera Paula,Kaplan-Lefko Paula,Chamie Karim,Belldegrun Arie S.,Pantuck Allan J.,Drakaki Alexandra

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference37 articles.

1. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

2. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018

3. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy;Bui;Clin Cancer Res,2003

4. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma;Leppert;BJU Int,2005

5. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma;Pantuck;J Clin Oncol,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses;Pathogens;2024-05-23

2. Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment;Molecules;2024-03-25

3. The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment;Current Issues in Molecular Biology;2023-10-01

4. The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma;npj Vaccines;2023-08-04

5. Nanomedicine for Combination Urologic Cancer Immunotherapy;Pharmaceutics;2023-02-06